Ingrid Garajová

Country flagItaly

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Year:

2026

Year:

2026

Year:

2026

Pancreatic ductal adenocarcinoma remains associated with a poor prognosis, even when diagnosed at an early stage. Consequently, it is imperative to carefully consider the available therapeutic options and tailor them based on clinically relevant biomarkers. In our comprehensive review, we specifically concentrated on the identification of novel predictive and prognostic markers that have the potential to be integrated into multiparametric scoring systems. These scoring systems aim to accurately predict the efficacy of neoadjuvant chemotherapy in surgically resectable pancreatic cancer cases. By identifying robust predictive markers, we can enhance our ability to select patients who are most likely to benefit from neoadjuvant chemotherapy. Furthermore, the identification of prognostic markers can provide valuable insights into the overall disease trajectory and inform treatment decisions. The development of multiparametric scoring systems that incorporate these markers holds great promise for optimizing the selection of patients for neoadjuvant chemotherapy, leading to improved outcomes in resectable pancreatic neoplasia. Continued research efforts are needed to validate and refine these markers and scoring systems, ultimately advancing the field of personalized medicine in pancreatic adenocarcinoma management.

Year:

2023

Collaborators (22)

Jeroen Dekervel

-

BELGIUM
View details

Fabian Finkelmeier

University Hospital Frankfurt

GERMANY
View details

Stephen Chan

The Chinese University of Hong Kong (CUHK)

HONG KONG
View details

LUCA MORELLI

Professore Associato in Chirurgia Generale

University of Pisa

ITALY
View details

David J. Pinato

Imperial College London

UNITED KINGDOM
View details

Mario Scartozzi

-

ITALY
View details

Hong Jae Chon

Associate Professor

CHA Bundang Medical Center

SOUTH KOREA
View details

Elisa Giovannetti

-

NETHERLANDS
View details

Salvatore Corallo

Researcher

University of Pavia

ITALY
View details

Fabio Gelsomino

-

ITALY
View details

ilhwan kim

Associate Professor

Inje University Ilsan Paik Hospital

SOUTH KOREA
View details

Jin Won Kim

Professor

Seoul National University Hospital

SOUTH KOREA
View details

Giovanni Farinea

University of Turin

ITALY
View details

Antonio Avallone

Chief of DH Chemotherapy

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY
View details

Sara Lonardi

Head of Dept

Istituto Oncologico Veneto

ITALY
View details

Matteo Landriscina

Professor of Medical Oncology

Università degli Studi di Foggia

ITALY
View details

Chiara Braconi

Chair in HepatoBiliary Oncology

University of Glasgow

UNITED KINGDOM
View details

Monica Niger

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY
View details

Lorenzo Antonuzzo

University of Florence

ITALY
View details

Lorenza Rimassa

Head of Hepatopancreatobiliary Oncology Unit

Humanitas University

ITALY
View details

Andrea Cavazzoni

Assistant professor

University of Parma

ITALY
View details

Arndt Vogel

Hannover Medical School

GERMANY
View details